LATEST ARTICLES

Kidney Cancer Journal Volume 17, Number 1
Where do you go for reliable, insightful, and late-breaking news online? Beginning April 15, the Kidney Cancer Journal will unveil dramatic changes to its website
Kidney Cancer Journal 2018 Issues
Kidney Cancer Journal Volume 17, Number 1
In this interview, a representative from the clinical development team of Calithera Biosciences discusses the potential impact of a novel drug combination undergoing study in
Kidney Cancer Journal Volume 17, Number 1
This is GU ASCO 2.0, a fresh, intuitive, yet evidence-based analysis. In this wide ranging interview, Dr Vogelzang drills beyond the data to build a translational framework for
Thomas J. Metzner, MS1,2, Christian R. Hoerner, PhD2,3, Hongjuan Zhao, PhD 1, Rosalie Nolley, MS1, Sumit A. Shah, MD2,3, Sandy Srinivas, MD2,3, John P. Higgins, MD2,4, Chia-Sui Kao, MD2, Rajesh P. Shah, MD2,5,9, Joanna E. Liliental, PhD2,6, Alan E. Thong, MD MPH1,2, Harcharan S. Gill, MD1,2, Benjamin I. Chung,...
Kidney Cancer Journal Volume 17, Number 1
Long-term responders (LTRs) are defined by at least 18 months of response to sunitinib in metastatic clear-cell renal cell carcinoma (ccRCC). The phenotype of these
Kidney Cancer Journal Volume 17, Number 1
Kidney Cancer Journal Volume 17, Number 1
Exciting original research was reported at this year’s 17th International Kidney Cancer Symposium (IKCS) in Miami. With “Emerging Concepts and Therapeutic Trials in Progress in RCC” as one of the
ESMO 2018 provided a multi-professional platform for oncology education and exchange, and offered immense international visibility for scientific research. This year
Small renal masses (SRM), defined as solid cortical neoplasms of the kidney less than 4 cm, comprise approximately 40% of all newly diagnosed renal tumors and are